ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 35 filers reported holding ONCOCYTE CORP in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $472,000 | -50.9% | 189,600 | -22.1% | 0.22% | -51.8% |
| Q1 2019 | $961,000 | +92.2% | 243,400 | +189.9% | 0.46% | +109.2% |
| Q1 2017 | $500,000 | -15.5% | 83,958 | 0.0% | 0.22% | -24.8% |
| Q4 2016 | $592,000 | +107.0% | 83,958 | +47.8% | 0.29% | +154.4% |
| Q3 2016 | $286,000 | +17.2% | 56,800 | -17.1% | 0.11% | +5.6% |
| Q2 2016 | $244,000 | -14.4% | 68,495 | +10.8% | 0.11% | +6.9% |
| Q1 2016 | $285,000 | – | 61,817 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 1,093,219 | $6,833,000 | 1.15% |
| HUNTINGTON NATIONAL BANK | 10 | $0 | 0.00% |
| CITIGROUP INC | 642 | $4,000 | 0.00% |
| Sonora Investment Management, LLC | 50 | $0 | 0.00% |
| BARCLAYS PLC | 206 | $1,000 | 0.00% |
| BLACKROCK ADVISORS LLC | 96 | $1,000 | 0.00% |